ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

GASACROL MANGO

Product Packing: 170 ML

Product Composition: Magaldrate 400 mg + Simethicone 20 mg

Product Price: MRP : 98

GASACROL MANGO

Magaldrate 400 mg + Simethicone 20 mg | SUSP. 170 ML

GASACROL MANGO is an oral suspension containing Magaldrate and Simethicone. Magaldrate is an antacid that neutralizes gastric acid, while Simethicone is an antiflatulent that helps reduce the surface tension of gas bubbles. The formulation should be used according to the current approved product label and healthcare professional guidance.

Magaldrate provides acid-neutralizing action for short-term relief of selected acid-related symptoms, while Simethicone helps dispersed gas bubbles combine and pass more easily. The supplied strengths are preserved exactly, but because no per-volume basis was supplied, the exact concentration per ml or measured dose must be verified from the approved product label.

Composition

Each labelled dose contains:

·         Magaldrate - 400 mg

·         Simethicone - 20 mg

·         Suspension base / excipients - q.s. | Mango flavour as per approved formulation. The supplied brief does not state the measured volume to which the strengths apply; exact concentration per ml/measured dose must be verified from the approved product label.

Dosage form: Oral Suspension

Pack size: 170 ml

Uses of GASACROL MANGO

GASACROL MANGO may be used for short-term symptomatic relief of selected acid-related and gas-related gastrointestinal complaints where this combination is approved and clinically appropriate.

·         Magaldrate helps neutralize excess gastric acid and may relieve symptoms such as heartburn or acid indigestion

·         Simethicone helps reduce discomfort associated with trapped intestinal or gastric gas

·         The combination may provide symptomatic support where acidity and gas occur together

·         Mango flavour provides the stated flavour profile; it does not alter the therapeutic role of the active ingredients

Persistent or recurrent heartburn, difficulty swallowing, gastrointestinal bleeding, repeated vomiting, severe abdominal pain, unexplained weight loss or anemia-related symptoms require medical evaluation.

How GASACROL MANGO Works

GASACROL MANGO combines an antacid and an antiflatulent:

Magaldrate: Reacts with gastric acid to provide acid-neutralizing activity and raise gastric pH for symptomatic relief.

Simethicone: Acts physically in the gastrointestinal tract by reducing the surface tension of gas bubbles, allowing them to coalesce and pass more easily.

The overall response depends on the underlying cause of symptoms, exact dose, timing, diet, concurrent medicines and individual clinical status.

Antacids provide symptomatic relief but do not diagnose or treat every cause of persistent dyspepsia, reflux-like symptoms or abdominal discomfort.

Frequent or prolonged symptoms should be clinically assessed rather than managed indefinitely with self-treatment.

 

Dosage and Direction for Use

Use GASACROL MANGO according to the approved product label or healthcare professional's advice. The supplied brief lists Magaldrate 400 mg and Simethicone 20 mg but does not state the volume containing these strengths, so no per-ml or per-5-ml dose has been inferred.

Shake the suspension well before use and measure the recommended quantity accurately with a calibrated measuring cup, spoon or oral syringe as appropriate.

Antacids can affect absorption of other oral medicines. Appropriate spacing from other medicines may be required according to medicine-specific guidance.

Do not exceed the recommended dose or use for prolonged periods without professional advice, particularly in patients with kidney disease or those taking multiple medicines.

Possible Side Effects

Possible adverse effects may include:

·         Constipation or diarrhoea, depending on individual response and the antacid formulation

·         Nausea, abdominal discomfort or altered bowel habits

·         Simethicone is generally minimally absorbed, but hypersensitivity to ingredients or excipients is possible

·         Prolonged or excessive antacid use may contribute to mineral or electrolyte disturbances, particularly in susceptible patients

·         Seek medical attention for severe abdominal pain, persistent vomiting, black or bloody stools, significant allergic reaction, marked weakness or other serious symptoms.

Any persistent or troublesome adverse effect should be discussed with a healthcare professional.

Precautions and Contraindications

·         Review the complete approved label before use, particularly in patients with kidney disease, electrolyte disorders, persistent gastrointestinal symptoms or those taking medicines with absorption-sensitive dosing.

·         Avoid use in patients with known hypersensitivity to Magaldrate, Simethicone or any formulation excipient.

·         Patients with significant renal impairment require professional assessment because antacid components and mineral exposure may be clinically relevant.

·         Do not use repeated antacid treatment to mask persistent or alarm gastrointestinal symptoms without appropriate evaluation.

·         Antacids may change gastric pH or bind/interfere with other medicines, so dose separation may be necessary.

·         Pregnancy, breastfeeding, infants, children and patients with chronic gastrointestinal disease require appropriate approved-label and professional guidance.

·         Check sweeteners, mango flavour ingredients, preservatives and potential allergens on the final approved label.

·         Keep out of reach of children and store according to the approved pack instructions.

·         Drug Interaction Considerations

·         Antacids can reduce or alter the absorption of several oral medicines, including certain antibiotics, iron, thyroid medicines and other drugs. The required spacing varies by medicine, so current product-specific guidance should be followed.

·         Provide the healthcare professional with a complete list of prescription medicines, OTC gastrointestinal products, vitamins, minerals and supplements before regular use.

Business Growth Opportunity with GASACROL MANGO

GASACROL MANGO offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Magaldrate + Simethicone oral suspension in a convenient 170 ml mango-flavoured pack to their gastrointestinal-care portfolio.

Antacid and antiflatulent combinations are an established therapeutic segment. Promotion must remain consistent with the final approved composition, indications, permitted claims, ethical pharmaceutical practice and applicable regulations.

 

Key Business Advantages

·         Magaldrate + Simethicone combination

·         Antacid + antiflatulent product concept

·         Mango-flavoured oral suspension

·         Convenient 170 ml pack

·         Suitable addition to gastrointestinal-care portfolios subject to approved formulation and indications

·         Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for GASACROL MANGO

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for GASACROL MANGO in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids consistent with approved claims

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for GASACROL MANGO and other quality-focused healthcare products.

Third-Party Manufacturing Support for Magaldrate + Simethicone Suspension

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to GASACROL MANGO under their own brand, subject to applicable drug licensing, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized approved strengths, flavour and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed gastrointestinal oral-suspension portfolio.

Frequently Asked Questions About GASACROL MANGO

1. What is GASACROL MANGO?

GASACROL MANGO is a 170 ml oral suspension containing Magaldrate 400 mg and Simethicone 20 mg according to the supplied product brief.

2. What does Magaldrate do?

Magaldrate is an antacid that neutralizes gastric acid and may provide short-term relief of selected acid-related symptoms.

3. What is the role of Simethicone?

Simethicone is an antiflatulent that helps gas bubbles combine and pass more easily, reducing gas-related discomfort.

4. Is GASACROL MANGO used for both acidity and gas?

The combination provides antacid and antiflatulent actions and may be used where both types of symptoms are present and the product is clinically appropriate.

5. Should GASACROL MANGO be separated from other medicines?

Possibly. Antacids can interfere with absorption of some oral medicines, so medicine-specific spacing instructions should be followed.

6. How should GASACROL MANGO be taken?

Shake well and follow the approved label or healthcare professional's directions. The supplied strengths have no stated per-volume basis, so the exact measured dose must be verified from the approved label.

7. Is a PCD Pharma Franchise available for GASACROL MANGO?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Magaldrate + Simethicone suspension may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

Disclaimer

GASACROL MANGO product information in this document is for general professional and business information. The supplied product brief states Magaldrate 400 mg + Simethicone 20 mg, SUSP. 170 ML, with MANGO indicated; mango has been treated as the stated flavour descriptor. The brief does not state the measured volume to which these strengths apply, so no per-ml or per-5-ml concentration has been inferred. Exact composition, concentration per measured dose, flavour/excipient specification, approved age range, indications, dosage, contraindications, warnings, interactions and regulatory status must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Persistent or alarm gastrointestinal symptoms require appropriate clinical assessment. This document is not a substitute for professional medical advice.

Contact